ATRX loss promotes immunosuppressive mechanisms in IDH1 mutant glioma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ATRX loss promotes immunosuppressive mechanisms in IDH1 mutant glioma
Authors
Keywords
-
Journal
NEURO-ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2021-12-18
DOI
10.1093/neuonc/noab292
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PARP Inhibitors for Sensitization of Alkylation Chemotherapy in Glioblastoma: Impact of Blood-Brain Barrier and Molecular Heterogeneity
- (2019) Shiv K. Gupta et al. Frontiers in Oncology
- Harnessing Radiation Biology to Augment Immunotherapy for Glioblastoma
- (2019) Karishma R. Rajani et al. Frontiers in Oncology
- G-quadruplex DNA drives genomic instability and represents a targetable molecular abnormality in ATRX-deficient malignant glioma
- (2019) Yuxiang Wang et al. Nature Communications
- IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response
- (2019) Felipe J. Núñez et al. Science Translational Medicine
- Generation of monocyte-derived tumor-associated macrophages using tumor-conditioned media provides a novel method to study tumor-associated macrophages in vitro
- (2019) Brooke Benner et al. Journal for ImmunoTherapy of Cancer
- Loss of ATRX suppresses ATM dependent DNA damage repair by modulating H3K9me3 to enhance temozolomide sensitivity in glioma
- (2018) Bo Han et al. CANCER LETTERS
- Mutant IDH1 Cooperates with ATRX Loss to Drive the Alternative Lengthening of Telomere Phenotype in Glioma
- (2018) Joydeep Mukherjee et al. CANCER RESEARCH
- The oncometabolite D-2-hydroxyglutarate is an intercellular mediator in IDH-mutant gliomas that inhibits both complement and T cells
- (2018) Lingjun Zhang et al. CLINICAL CANCER RESEARCH
- Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate
- (2018) Lukas Bunse et al. NATURE MEDICINE
- Heterozygous IDH1R132H/WT created by “single base editing” inhibits human astroglial cell growth by downregulating YAP
- (2018) Shuang Wei et al. ONCOGENE
- Ribosomal DNA copy loss and repeat instability in ATRX-mutated cancers
- (2018) Maheshi Udugama et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Atrx inactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodeling
- (2018) Carla Danussi et al. Nature Communications
- The IDH1 Mutation-Induced Oncometabolite, 2-Hydroxyglutarate, May Affect DNA Methylation and Expression of PD-L1 in Gliomas
- (2018) Luyan Mu et al. Frontiers in Molecular Neuroscience
- Mutant IDH1 regulates the tumor-associated immune system in gliomas
- (2017) Nduka M. Amankulor et al. GENES & DEVELOPMENT
- Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas
- (2017) Gary Kohanbash et al. JOURNAL OF CLINICAL INVESTIGATION
- IL-6 Regulates M2 Polarization and Local Proliferation of Adipose Tissue Macrophages in Obesity
- (2017) Julia Braune et al. JOURNAL OF IMMUNOLOGY
- Induction of PD-L1 expression by epidermal growth factor receptor–mediated signaling in esophageal squamous cell carcinoma
- (2017) Wencheng Zhang et al. OncoTargets and Therapy
- DNA double-strand break repair pathway regulates PD-L1 expression in cancer cells
- (2017) Hiro Sato et al. Nature Communications
- Comprehensive analysis of PD-L1 expression in glioblastoma multiforme
- (2017) Dieter Henrik Heiland et al. Oncotarget
- Low-Grade Astrocytoma Mutations in IDH1, P53, and ATRX Cooperate to Block Differentiation of Human Neural Stem Cells via Repression of SOX2
- (2017) Aram S. Modrek et al. Cell Reports
- Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
- (2017) Angel Garcia-Diaz et al. Cell Reports
- ATRX binds to atypical chromatin domains at the 3′ exons of zinc finger genes to preserve H3K9me3 enrichment
- (2016) David Valle-García et al. Epigenetics
- The role of microglia and macrophages in glioma maintenance and progression
- (2016) Dolores Hambardzumyan et al. NATURE NEUROSCIENCE
- ATRX loss promotes tumor growth and impairs nonhomologous end joining DNA repair in glioma
- (2016) Carl Koschmann et al. Science Translational Medicine
- Interleukin-33 in human gliomas: Expression and prognostic significance
- (2016) DOROTHEE GRAMATZKI et al. Oncology Letters
- CXCL9 Is Important for Recruiting Immune T Cells into the Brain and Inducing an Accumulation of the T Cells to the Areas of Tachyzoite Proliferation to Prevent Reactivation of Chronic Cerebral Infection with Toxoplasma gondii
- (2015) Eri Ochiai et al. AMERICAN JOURNAL OF PATHOLOGY
- Isocitrate dehydrogenase 1 and 2 mutations induce BCL-2 dependence in acute myeloid leukemia
- (2015) Steven M Chan et al. NATURE MEDICINE
- Survival and low-grade glioma: the emergence of genetic information
- (2015) Elizabeth B. Claus et al. Neurosurgical Focus
- Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Whole-exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma
- (2015) Kasthuri Kannan et al. Oncotarget
- PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation
- (2014) Muhammad Zaeem Noman et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma
- (2013) B. E. Johnson et al. SCIENCE
- Interleukins in glioblastoma pathophysiology: implications for therapy
- (2012) YT Yeung et al. BRITISH JOURNAL OF PHARMACOLOGY
- A heterozygous IDH1R132H/WT mutation induces genome-wide alterations in DNA methylation
- (2012) C. G. Duncan et al. GENOME RESEARCH
- Altered Telomeres in Tumors with ATRX and DAXX Mutations
- (2011) C. M. Heaphy et al. SCIENCE
- Loss of Maternal ATRX Results in Centromere Instability and Aneuploidy in the Mammalian Oocyte and Pre-Implantation Embryo
- (2010) Claudia Baumann et al. PLoS Genetics
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now